Altogether, the patient prognostic and stratification value (relevant for nucleolin-based therapeutic interventions) of nucleolin mRNA expression should account for the histopathological subtype of lung cancer and further integrate an analysis at the protein level. The gene discussed is NUCLEOLIN; the disease is lung carcinoma.